Cyclopharm Future Growth
Future criteria checks 6/6
Cyclopharm is forecast to grow earnings and revenue by 89.2% and 31.7% per annum respectively. EPS is expected to grow by 89.1% per annum. Return on equity is forecast to be 45.9% in 3 years.
Key information
89.2%
Earnings growth rate
89.1%
EPS growth rate
Medical Equipment earnings growth | 16.6% |
Revenue growth rate | 31.7% |
Future return on equity | 45.9% |
Analyst coverage | Low |
Last updated | 06 May 2024 |
Recent future growth updates
Recent updates
Earnings and Revenue Growth Forecasts
Date | Revenue | Earnings | Free Cash Flow | Cash from Op | Avg. No. Analysts |
---|---|---|---|---|---|
12/31/2026 | 68 | 16 | 15 | 18 | 1 |
12/31/2025 | 48 | 6 | 6 | 9 | 1 |
12/31/2024 | 32 | -8 | -10 | -8 | 1 |
12/31/2023 | 27 | -5 | -8 | -7 | N/A |
9/30/2023 | 28 | -6 | -8 | -7 | N/A |
6/30/2023 | 29 | -7 | -8 | -7 | N/A |
3/31/2023 | 27 | -7 | -8 | -7 | N/A |
12/31/2022 | 25 | -7 | -8 | -7 | N/A |
9/30/2022 | 24 | -5 | -6 | -4 | N/A |
6/30/2022 | 23 | -4 | -4 | -2 | N/A |
3/31/2022 | 21 | -4 | -3 | -2 | N/A |
12/31/2021 | 20 | -5 | -3 | -2 | N/A |
9/30/2021 | 20 | -5 | -5 | -4 | N/A |
6/30/2021 | 20 | -4 | -7 | -6 | N/A |
3/31/2021 | 19 | -5 | -8 | -8 | N/A |
12/31/2020 | 18 | -6 | -9 | -9 | N/A |
9/30/2020 | 17 | -6 | -7 | -7 | N/A |
6/30/2020 | 16 | -6 | -6 | -5 | N/A |
3/31/2020 | 17 | -4 | -3 | -3 | N/A |
12/31/2019 | 17 | -3 | -1 | 0 | N/A |
9/30/2019 | 16 | -3 | -1 | 0 | N/A |
6/30/2019 | 16 | -2 | -1 | 0 | N/A |
3/31/2019 | 16 | -1 | -1 | -1 | N/A |
12/31/2018 | 16 | 0 | -2 | -1 | N/A |
9/30/2018 | 16 | 0 | -2 | -1 | N/A |
6/30/2018 | 16 | -1 | -1 | 0 | N/A |
3/31/2018 | 16 | -1 | -2 | 0 | N/A |
12/31/2017 | 16 | -2 | -2 | -1 | N/A |
9/30/2017 | 15 | -1 | N/A | 0 | N/A |
6/30/2017 | 14 | -1 | N/A | 0 | N/A |
3/31/2017 | 15 | 0 | N/A | 0 | N/A |
12/31/2016 | 15 | 1 | N/A | 1 | N/A |
9/30/2016 | 14 | 3 | N/A | 2 | N/A |
6/30/2016 | 14 | 5 | N/A | 4 | N/A |
3/31/2016 | 13 | 5 | N/A | 4 | N/A |
12/31/2015 | 13 | 5 | N/A | 4 | N/A |
9/30/2015 | 12 | 4 | N/A | 4 | N/A |
6/30/2015 | 11 | 3 | N/A | 4 | N/A |
3/31/2015 | 11 | 4 | N/A | 4 | N/A |
12/31/2014 | 12 | 4 | N/A | 4 | N/A |
9/30/2014 | 13 | -2 | N/A | 3 | N/A |
6/30/2014 | 14 | -8 | N/A | 2 | N/A |
3/31/2014 | 13 | -9 | N/A | 1 | N/A |
12/31/2013 | 12 | -10 | N/A | 1 | N/A |
9/30/2013 | 12 | -6 | N/A | 0 | N/A |
Analyst Future Growth Forecasts
Earnings vs Savings Rate: CYC is forecast to become profitable over the next 3 years, which is considered faster growth than the savings rate (2.3%).
Earnings vs Market: CYC is forecast to become profitable over the next 3 years, which is considered above average market growth.
High Growth Earnings: CYC is expected to become profitable in the next 3 years.
Revenue vs Market: CYC's revenue (31.7% per year) is forecast to grow faster than the Australian market (5.4% per year).
High Growth Revenue: CYC's revenue (31.7% per year) is forecast to grow faster than 20% per year.
Earnings per Share Growth Forecasts
Future Return on Equity
Future ROE: CYC's Return on Equity is forecast to be very high in 3 years time (45.9%).